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Natural killer (NK) cells express killer cell inhibitory receptors (KIRs) that recognize polymorphic class I MHC molecules. In
the present study, we analyze the modulatory eﬀect of IL-2 alone or a combination of IL-12 with IL-18 on surface expression of
killer cell immunoglobulin-like receptors KIR2DL1, KIR2DL2, and KIR3DL2 in NK cells. Thus, it was found that IL-2 causes a
signiﬁcant increase in the proportion of cells with given studied receptors. Stimulation by a mixture of IL-12 and IL-18 caused
signiﬁcant increase in the fraction of cells with the KIR2DL1 and KIR2DL2, however no signiﬁcant change in the percentage of
cells with KIR3DL2 receptor on their surface was observed. The results of the study show the presence of KIRs on both resting
and activated NK cells, this may suggest that KIRs have also an important role in the regulatory processes after activation of this
subpopulation of cells.
Copyright © 2006 Slawomir Chrul et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
INTRODUCTION
Natural killer (NK) cells are a key component of an innate
immune defense [1, 2]. They are involved both in the con-
trol of viral infections and elimination of tumor cells. NK
cells are a subset of mononuclear cells which have long been
suspected of playing an immunoregulatory role in the pre-
vention of autoimmune diseases (reviewed in [3]). Their ac-
tivity can be described as nonadaptive and independent of
MHCrestriction[4,5].AvarietyofNKcellfunctionssuchas
cytotoxicity,proliferation,chemotaxis,andcytokineproduc-
tion are modulated by regulatory cytokines including IFN-α,
IL-2, IL-12, IL-18, IL-10, and TNF [6, 7]. In addition, NK
cells secrete cytokines, such as IFN and TNF, during infec-
tion and inﬂammation [6]. NK cells express members of a
multigenic family of killer cell inhibitory receptors (KIRs)
that recognize polymorphic class I MHC molecules on tar-
get cells protecting healthy cells from destruction while en-
abling killing of abnormal cells [8–10]. Based on the number
of extracellular Ig domains, two families of KIR can be dis-
tinguished and they have either short (S) or long (L) intra-
cytoplasmic tails which transduce activating and inhibitory
signals, respectively. KIR2D (with two Ig domains) interacts
with HLA-C allotypes, while KIR3D (with three Ig domains)
interacts with HLA-B molecules that display the Bw4 epitope
(KIR3DL1) or with HLA-A alleles (KIR3DL2). Functional
analysis showed that HLA-A3 or HLA-A11 molecules could
inhibit lysis mediated by NK cells expressing the KIR3DL2
[11, 12]. Genes encoding KIR2DL1 and KIR2DL2/3 are
present in virtually all Caucasoid individuals [13, 14]. How
could KIR-expressing cells play a role in initiating autoim-
munity? Recognition of HLA class 1 by activating KIRs on
both natural killer and T-cell subsets may aﬀect the immune
response through the secretion of interferon-document and
other possible T-helper 1 cytokine [15]. KIRs may also be
important in the regulation of peripheral tolerance of T-cell
subsets. Activating KIRs, combined with insuﬃcient regula-
tion of T-cell autoreactivity by inhibitory KIR, may facilitate
the activation of autoreactive T cells that are breaking toler-
ance for self-antigens. A genetic imbalance between activat-
ing and inhibitory KIR genes may inﬂuence the pathogenesis
of autoimmune diseases, either via upregulated activation or
lack of inhibition or both.
A variety of data indicate that self-tolerance of NK cells
can be broken in some instances by culturing these cells
in high doses of IL-2 [16–18]. NK cells are known to be
highly responsive to many biological agents including cy-
tokinessuchasIL-2,IL-12,andIL-15andinterferons(IFNs),2 Mediators of Inﬂammation
and to rapidly increase their cytolytic, secretory, prolifera-
tive, and other functions upon stimulation with these agents.
Cytolytic activity of NK cells is augmented by IL-2 and IL-
15 through the IL-2Rb chain (CD122) [19]. IL-2 potentates
both growth and cytotoxic functions of NK cells with rapid
activation of CD69 antigen [20]. Interleukin 18(IL-18) was
discovered as an interferon-γ (IFN-γ)-inducing factor and
plays an important role in NK cell activation [21]. IL-18 sim-
ilarly to IL-12, augments NK activity through the induction
of constitutively expressed IL-18 receptor (IL-18R) on NK
cells [22]. IL-2 alone, or in combination with IL-12 or IL-18,
has a strong ability to induce NK cell responses [23]. Inter-
estingly, NK cells stimulated with IL-12/IL-18 secrete large
amounts of IFN-, whereas NK cells grown in IL-2 or IL-15
do not [24]. Also, a striking synergy between IL-12 and IL-18
wasobservedindiﬀerentmodelsystems[25–29].Thereports
on the eﬀect of the above discussed cytokines on the presen-
tation of KIRs on NK cells surface are scarce. The authors
usually, among selected immunological parameters, evalu-
ate the reaction of the KIR2DL1 receptor after stimulation
withIL-2[30–32].Theseinteractionsseemhighlyinteresting
since the involvement of these KIRs in pathological reactions
was proved. Abnormal presentation of the KI2DL1 may con-
tribute to one of immunological deﬁciency syndromes [33].
The KIR2DL2 receptors are connected with the pathogenesis
of sclerodermia [34] and the KIR3DL2 receptors with Sezary
syndrome[35].Lymphoproliferativediseaseofgranularlym-
phocytes (LDGL) is associated with the increased activating-
to-inhibitoryKIRratio[36].Thedecreasedactivationpoten-
tial of NK cells associated with KIR/HLA genotypes may pre-
dispose to microscopic polyangiitis, possibly through insuf-
ﬁcient resistance against infections [37].
In the present study, we analyze the modulatory eﬀect
of IL-2 alone or a combination of IL-12 with IL-18 on sur-
face expression of killer cell immunoglobulin-like receptors
KIR2DL1, KIR2DL2, and KIR3DL2 in NK cells.
MATERIAL AND METHODS
The study was approved by the Local Ethical Committee and
a written consent was given for all participants according
to the Declaration of Helsinki. Heparinized venous blood
was taken from 20 Caucasoid healthy controls identiﬁed as
follows: 8 females and 12 males with a mean age ± SD of
7.5 ±2.5y e a r s .
IsolationofNKcells
Peripheral blood mononuclear cells (PBMC) were isolated
from buﬀy coats after density gradient centrifugation over
Histopaque 1077 (Sigma-Aldrich, Inc, St Louis, Mo, USA).
For further immunomagnetic separation of NK cells from
the PBMC subjects, the magnetic cell separation (MACS)
system (Miltenyi Biotech, Gladbach, Germany) was used.
This method is an indirect magnetic labeling system for de-
pletion of human T cells, B cells, and myeloid cells from
PBMC to enrich untouched NK cells (negative selection).
Non-NK cells were indirectly labeled with a cocktail of
biotin-conjugatedmonoclonalantibodiesagainstCD3,CD4,
CD14, CD15, CD19, CD36, CD123, and with Glycophorin
A as primary labeling reagent, and antibiotin monoclonal
antibodies conjugated to MicroBeads, as a secondary label-
ing reagent. The magnetically labeled non-NK cells were de-
pleted by retaining them in a column in the magnetic ﬁeld
whiletheunlabeledNKcellspassedthroughthecolumn.Pu-
riﬁcation of NK cells was executed according to the man-
ufacturer’s directions. After isolation, NK cells were stained
with ﬂuorochrome-conjugated antibodies directed against
cell surface antigens anti-CD3-FITC, CD16+56PE (BD Bio-
sciences, Immunocytometry Systems, San Jose, Calif, USA).
FACS analyses were performed using FACSCalibur and Cel-
lQuest software (BD Biosciences, Immunocytometry Sys-
tems, San Jose, Calif, USA). Purity of separated cells was
> 95%.
NKcellscultureinvitro
Freshly puriﬁed NK cells (1×106/mL) were cultured in com-
plete RPMI 1640 medium containing 25mM HEPES, 2mM
L-glutamine, 100μg/mL streptomycin, 100U/mL penicillin,
10mM sodium pyruvate solution (Sigma-Aldrich, Inc, St
Louis, Mo, USA) and 10% heat-inactivated FCS (Invitro-
gen, Carlsbad, USA) without any exogenous cytokine. NK
cells were incubated in humidiﬁed 5% CO2 atmosphere at
37◦C for 72 hours in the presence or absence of recombinant
human cytokines. For activation, puriﬁed NK cells were in-
cubated with IL-2 (10ng/mL) or IL-12 (10ng/mL) and IL-
18 (100ng/mL). Puriﬁed rhIL-2 was provided by Seromed-
Biochrom (Berlin, Germany). Puriﬁed rhIL-12 was obtained
fromPeprotechEC (London, UK). Puriﬁed rhIL-18waspro-
videdbyProSpec-TanyTechnoGene(Rehovot,Israel).Allcy-
tokines were endotoxin free.
ImmunoﬂuorescencestainingandFACSanalysis
After 72 hours, cultured NK cells were washed with PBS,
stained, and analyzed phenotypically. The following FITC-,
PE-, PerCP- or tricolour-labeled antibody speciﬁcities were
used for the analysis of cell surface markers, CD69-PE-
Cy, CD158a (KIR2DL1)-FITC, CD158b (KIR2DL2)-PE (BD
Pharmingen San Diego, Calif, USA). Cells were stained
with ﬂuorochrome-conjugated antibodies directed against
cell surface antigens according to the manufacturer’s instruc-
tion. For staining of KIR3DL2, indirect immunoﬂuorescence
method was used. Cells were incubated ﬁrst with uncon-
jugated Q66 mAb ( anti-p140 IgM, KIR3DL2), a gift from
Daniela Pende (Istituto Nazionale per la Ricerca sul Cancro,
Genova,Italia),for60minutesatroomtemperature,washed,
and incubated with PE-conjugated goat antimouse IgM an-
tibodies (Southern Biotechnology Associates, Birmingham,
Ala, USA) for 30 minutes at room temperature. After wash-
ing, cells were analyzed by ﬂow cytometry.
FACS analysis was performed using FACSCalibur ﬂow
cytometry with Cell Quest software (Becton Dickinson, Im-
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MeasurementofNKcellcytokineproteinin
cellculturesupernatants
After 72 hours, cell-free culture supernatants were harvested,
centrifuged to remove all cells and debris, and frozen at
−70◦C for later analysis with cytokines by ELISA. Super-
natants underwent only one freeze-thaw cycle before quan-
tiﬁcation by ELISA. Culture supernatants were tested in du-
plicate.
The production of IFN-γ protein by NK cells was mea-
sured from cell-free culture supernatants with commercial
ELISA kits (BioSource International, Camarillo, Calif, USA),
following the manufacturers’ instructions.
Statisticalanalysis
The diﬀerences between groups were analyzed by Wilcoxon
signed rank test, the Mann-Whitney U-test and, if appropri-
ate, by paired or unpaired t test. P<. 05 was considered to be
statistically signiﬁcant. All data were collected and analyzed
using the Statistica 6.0 program (StatSoft Inc, Tulsa, Okla,
USA).
RESULTS
EvaluationofNKcellsstimulation
Stimulation of NK cells was measured by two methods. First,
the concentration of IFN-γ in supernatant was determined.
In the control group the median of IFN-γ concentration was
4pg/mL. This value signiﬁcantly increased after stimulation
by IL-2 to 904pg/mL, and after stimulation by a mixture of
IL-12+IL-18 up to 1000pg/mL.
Secondly, an increase in a number of NK cells with CD69
antigen on their surface was determined. As compared to
10% in cells cultured without stimulating cytokines, after IL-
2 the number of cells increased, on average, to 82% and after
a mixture of IL-12 + IL-18 to 47%. Both values were signiﬁ-
cantlydiﬀerentfromthecontrolvalue.Thus,asuﬃcientlevel
of NK cells stimulation was achieved; this condition could be
used to assess the eﬀect on the studied KIRs.
ExpressionofKIRsonNKcellsafterstimulationwith
IL-2ormixtureofIL-12andIL-18
The expression of KIRs was determined using two methods.
First, a change in the number of NK cells with KIR2DL1,
KIR2DL2, KIR3DL3 receptors on their surface was evalu-
ated. Then, based on an assumption that the number of re-
ceptors on the surface of one cell is reﬂected in the num-
ber of antibodies binding to these receptors, distribution of
the cells population was evaluated based on the intensity of
ﬂuorescence. Median of the studied distributions was the
compared parameter.
Thus, it was found that IL-2 causes a signiﬁcant increase
in the proportion of cells with given receptors on their sur-
face,KIR2DL1,KIR2DL2,andKIR3DL2:by30%versus22%
(P<. 0001), 37% versus 30% (P<. 0001), and 24% versus
14% (P<. 0001), respectively. Stimulation by a mixture of
IL-12 + IL-18 caused signiﬁcant increase in the fraction of
cells with the studied receptors on their surface, KIR2DL1
andKIR2DL2:by26%versus22%(P<. 005)and33%versus
30% (P<. 005), respectively (Figure 1). However, no signiﬁ-
cantchangeinthepercentageofcellswithKIR3DL2receptor
on their surface was observed (15% versus 14%, P = .36).
The analysis of distribution of the ﬂuorescence inten-
sity revealed that IL-2 also caused signiﬁcant increase in the
numberoftheKIR2DL1andKIR2DL2receptorsonNKcells:
55 versus 33 (P<. 005) and 284 versus 209 (P<. 005), re-
spectively (Figure 2). Likewise, stimulation with a mixture
of IL-12 + IL-18 caused an increase in the number of these
receptors: 40 versus 33 (P<. 005) and 250 versus 209 (P<
.005), respectively. At the same time IL-2 had a signiﬁcant
strong eﬀect that resulted in the increase in the number of
cells with the KIR2DL1 receptor on their surface (P<. 05),
andtheincreaseinthenumberofthesereceptorsonNKcells
surface (P<. 05) as compared to IL-12+IL-18. Neither IL-2,
nor a mixture of cytokines IL-12 + IL-18, aﬀected the num-
ber of the KIR3DL2 receptors on one NK cells surface.
DISCUSSION
The population of NK cells, according to deﬁnition, is char-
acterised by autonomous cytotoxic ability. The principle of
biological systems functioning is based on a series of safety
measures operating in every case of potential autodestruc-
tion of the organism. Numerous publications of recent years
have shown nonhomogeneity of NK cells population. The
presence of regulatory and eﬀector subpopulations has been
documented [38, 39], as well as connection between the pro-
cess of NK cells activation with the activation of antigen pre-
senting cells [40, 41]. At the same time numerous reports
conﬁrm the presence of receptors on the surface of NK cells
which after binding to speciﬁc ligand play an important role
in the stimulation and/or inhibition of cytotoxicity. Among
these receptors there are KIRs with a long intraplasmatic
fragment. These receptors in contact with appropriate frag-
ment of HLA class I cause inhibition of NK cells cytotoxicity.
We have assumed that strong inhibitory action of these
receptors should be used in contraregulatory processes.
To verify this hypothesis, we have selected KIR2DL1 and
KIR2DL2 receptors, which cover the spectrum of HLA-C
antigens and HLA-A recognising KIR3DL2. NK were acti-
v a t e di na ni nvi t r oc u l t u r ei nt h ep r e s e n c eo fI L - 2a n dam i x -
ture of IL-12 + L-18. These cytokines, as it has been proved
in numerous publications, cause strong stimulation of NK
cells manifesting as, for example, increase of IFN-γ synthesis
by these cells. Despite numerous reports, which have doc-
umented the stimulatory eﬀect of cytokines IL-2, IL-12 and
IL-18onNKcells,veryfewweredevotedtotheireﬀectonthe
presentationofKIRs.Theauthorsconcentratedonthegroup
of the KIR2DL1 receptors of NK cells after stimulation by IL-
2 and increase in the number of these receptors was observed
[30–32]. Similarly, in our study, IL-2 was demonstrated to
increase a number of the KIR2DL1 and KIR2DL2 recep-
tors, however the reaction was much stronger in the case of
KIR2DL1 [42, 43]. Both reports have not demonstrated any4 Mediators of Inﬂammation
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Figure 1: Percentage of NK cells possessing KIR2DL1, KIR2DL2,
andKIR3DL2onthesurface.BothIL-2andIL-12+IL-18causedsig-
niﬁcantincreaseinthefractionofcellswithKIR2DL1andKIR2DL2
receptors whereas in the fraction of cells with KIR3DL2 receptors
only IL-2 caused signiﬁcant increase. ∗ denotes P<. 0001; ∗∗ de-
notes P<. 005; ∗∗∗denotes NS (nonsigniﬁcant).
signiﬁcant diﬀerences between cells populations exposed to
IL-12 and IL-18, and not exposed to these cytokines [42].
The results of our study indicate that, even though the reac-
tion of KIR receptors is smaller after IL-2, also in case of IL-2
statistically signiﬁcant increase in a number of the KIR2DL1
andKIR2DL2positiveNKcellsandalsoincreaseinthenum-
berofthesereceptorsonthesurfaceofoneNKcellwereseen.
These diﬀerences seem to be due to the application of an op-
timum mixture of synergistic cytokines in our study, while
in the above quoted study IL-12 and IL-18 were added to
separate cultures [44–47]. It may be also resulted from the
diﬀerent method of NK cells separation and application of
commercial antibodies in our study.
To date there have been no reports on the eﬀect of cy-
tokines IL-2 and IL-12+IL-18 on expression of the KIR3DL2
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Figure 2: Intensity of ﬂuorescence: estimation of the number of re-
ceptors KIR2DL1, KIR2DL2, and KIR3DL2 on the surface of NK
cells. Both IL-2 and IL-12 + IL-18 caused signiﬁcant increase in
the number of the KIR2DL1 and KIR2DL2 receptors on NK cells.
Neither IL-2, nor a mixture of cytokines IL-12 + IL-18, aﬀected the
number of the KIR3DL2 receptors. ∗ denotes P<. 005; ∗∗ denotes
NS (nonsigniﬁcant).
molecule. The study demonstrated that only IL-2 caused sig-
niﬁcant increase in a number of the cells positive for this re-
ceptor, although no change in the number of these receptors
on the surface of single NK cells was seen.
Theresultsofthisstudyandofotherreportsdemonstrate
that cytokines causing stimulation of NK cells cause an in-
crease in the number of NK cells with the studied KIRs on
the surface, and increase in the number of KIRs. At the same
time it should be noticed that this increase is much more
visible in a population of NK cells stimulated by IL-2. Thus,
indirectly, it was demonstrated that stimulation of NK cells
is a part of an autoregulatory mechanism. Increased num-
ber of KIRs on the surface of stimulated NK cells seems to
be one of the mechanisms sensitising these cells to suppres-
sion. On the other hand, diﬀerent behaviour of KIRs on NKSlawomir Chrul et al 5
cells after stimulation by various cytokines shows that this
process is selective. The presence of a large amount of IL-2 at
the site of immunologic reaction is seen mainly in the eﬀec-
tor stage of immunologic response. At this stage of response,
contraregulatory mechanisms seem most justiﬁed. However,
large amounts of cytokines IL-12 and IL-18 are seen mainly
in the recognition and antigen presentation stage. In this
stage NK cells contact dendritic cells (DC) and other APC
cells. This is the decisive stage as to the future of NK cells re-
action to the initial signals. At this stage contraregulation is
necessary for transfer of signals between NK and APC cells,
and activation of self-suppressor mechanisms seems to be of
smaller importance. The behaviour of KIR3DL2 receptors is
also interesting. Activation of IL-2 increases the number of
NK cells with these receptors, however it does not increase
their number on single cells. Also, there is no signiﬁcant re-
action after stimulation with the mixture of IL-12 + IL-18.
This may suggest that although all the studied proteins be-
long to the same family of receptors, various cytokines stim-
ulate their presentation to a diﬀerent degree. It may indicate
that particular receptors are part of diﬀerent pathways of NK
cells activation.
Moreover, since the KIRs have inhibitory properties and
are upregulated on activated NK cells, it is likely that these
receptors may play an important role in the contraregulatory
processes after activation of these cells.
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